Unknown

Dataset Information

Evaluation of Concurrent Chemoradiotherapy for Survival Outcomes in Patients With Synchronous Oligometastatic Esophageal Squamous Cell Carcinoma.


ABSTRACT:

Importance

The optimal treatment for and potential benefit populations of synchronous oligometastatic esophageal squamous cell carcinoma (SOESCC) remain unclear.

Objectives

To evaluate outcomes of concurrent chemoradiotherapy (CCRT) and to construct decision tree models for predicting the risk of progression and mortality in patients with SOESCC.

Design, setting, and participants

This prognostic study included 532 patients with SOESCC who were treated at 2 cancer centers in China from January 2012 to December 2018 and consisted of a development cohort (n = 381) and a validation cohort (n = 151). Data were analyzed from March 2019 to December 2021.

Exposures

All patients received chemotherapy alone or CCRT.

Main outcomes and measures

The primary end point

SUBMITTER: Shi Z 

PROVIDER: S-EPMC9716398 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature